COVID-19
Showing NaN - NaN of 39
COVID-19 Trial in United States (Apixaban 2.5 MG, Apixaban 5MG, Aspirin)
Terminated
- COVID-19
- Apixaban 2.5 MG
- +3 more
-
Los Angeles, California
- +70 more
Feb 15, 2022
COVID-19 Trial in New Orleans (Hydroxychloroquine, Azithromycin)
Terminated
- COVID-19
-
New Orleans, LouisianaUniversity Medical Center New Orleans
Jan 5, 2022
COVID-19, Corona Virus Infection, SARS (Severe Acute Respiratory Syndrome) Trial in United States (Hydroxychloroquine Sulfate,
Completed
- COVID-19
- +3 more
- Hydroxychloroquine Sulfate
- Ascorbic Acid
-
Los Angeles, California
- +7 more
Dec 14, 2021
COVID-19 Trial in United States (Hydroxychloroquine, Placebo oral tablet)
SARS-CoV-2/COVID-19 Prevalence Study
Completed
- COVID-19
-
Aurora, Colorado
- +14 more
Sep 29, 2021
SARS-CoV-2-specific Immunity in Individuals Who Have Recovered
Active, not recruiting
- SARS-CoV-2
- COVID-19
- Sample collection
-
Birmingham, Alabama
- +52 more
Sep 3, 2021
COVID-19 Trial in New Orleans (Biological: COVID-19 convalescent plasma)
No longer available
- COVID-19
- Biological: COVID-19 convalescent plasma
-
New Orleans, LouisianaTulane Medical Center
Mar 4, 2021
COVID-19 Trial in Worldwide (Remdesivir, Standard of Care)
COVID-19 Trial in Worldwide (Remdesivir, Standard of Care)
COVID-19 Trial in New Orleans (Hyperbaric Oxygen Therapy)
Unknown status
- COVID-19
- Hyperbaric Oxygen Therapy
-
New Orleans, LouisianaOchsner Medical Center
Apr 10, 2020